Accelerating clinical development and research funding are propelling the Rett Syndrome market forward. With novel therapeutic candidates advancing through trials and supportive global grant allocation, the rare disease landscape is shifting toward more targeted, disease-modifying treatment options and improved patient outcomes. https://www.einpresswire.com/article/833909472/rett-syndrome-market-expands-with-novel-therapies-and-global-research-surge-datam-intelligence